Action Potential Venture Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Portugal, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Romania
Industries Focus
- Healthcare
- Digital Health
- Pharmaceuticals
- Medical Devices
- Biotechnology
- Oncology
- Neurology
- Cardiology
- Endocrinology
- Health Technology
- Immunology
- Medical Technology
- Ophthalmology
- Orthopedics
- Gastroenterology
- Urology
- Pulmonology
- Rheumatology
- Dermatology
- Otolaryngology
Investment Size:
5,000,000 to 20,000,000 USD
Investor Details Founded: 2013
Action Potential Venture Capital (APVC) is a venture capital firm dedicated to advancing bioelectronic medicines and their enabling technologies. Founded in 2013 by GlaxoSmithKline (GSK), APVC invests globally in companies that are pioneering the development of bioelectronic medicines, a therapeutic field that leverages advances in hardware, computing, and material science to regulate neural or cellular activity for the treatment of chronic diseases. APVC takes an active role on the boards of start-ups, providing strategic guidance and support to accelerate the commercialization of innovative medical technologies.
APVC's investment strategy focuses on early to late-stage companies across various therapeutic areas, including oncology, neurology, cardiology, endocrinology, immunology, rheumatology, pulmonology, gastroenterology, orthopedics, ophthalmology, dermatology, urology, and otolaryngology. The firm seeks to invest in companies developing bioelectronic medicines and enabling technologies that can effectively treat a range of chronic diseases. APVC's portfolio includes companies such as SetPoint Medical, Alpheus Medical, MicroTransponder, Saluda Medical, and Cala Health.
APVC is committed to fostering an inclusive and diverse workspace and extends this commitment to the companies it invests in. The firm believes in the fundamental advantage of an inclusive and diverse workspace and is dedicated to creating a more equitable healthcare investor and entrepreneurial community. APVC's team comprises professionals with expertise in venture capital, bioelectronics, and medical technology, working collaboratively to identify and support innovative companies that have the potential to transform healthcare through bioelectronic medicines.
Requirements
- Companies developing bioelectronic medicines and enabling technologies
- Innovative medical technologies addressing chronic diseases
- Start-ups with potential for commercialization and scalability
- Companies with diverse and inclusive teams
- Entrepreneurial teams committed to advancing healthcare through bioelectronics
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- SetPoint Medical
- Alpheus Medical
- MicroTransponder
- Saluda Medical
- Cala Health
Mentioned In
-
$49.95
-
$14.95
-
$39.95
-
$19.95
-
$19.95
-
$24.95
-
$299.00
Claim this Investor
Are you an official representative of Action Potential Venture Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim